Determination of absolute concentrations of cardiac high-energy phosphates using 31P-MR-spectroscopy and SLOOP in healthy and diseased myocardium.

被引:16
作者
Beer, M
Landschütz, W
Meininger, M
Seyfarth, T
Viehrig, M
Sandstede, J
Pabst, T
Kenn, W
Horn, M
Harre, K
von Kienlin, M
Neubauer, S
Hahn, D
机构
[1] Univ Wurzburg, Inst Rontgendiagnost, D-97070 Wurzburg, Germany
[2] Univ Wurzburg, Inst Phys, D-97070 Wurzburg, Germany
[3] Univ Wurzburg, Med Klin, D-97070 Wurzburg, Germany
来源
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 1999年 / 171卷 / 01期
关键词
nuclear magnetic resonance; spectroscopy; high energy phosphate; quantitative measurements;
D O I
10.1055/s-1999-9896
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: A quantitative P-31-MR-spectroscopic technique was used to assess the energy metabolism in healthy and diseased myocardium. Methods: P-31-spectra were acquired on a 1.5 T scanner using a 3D-chemical shift imaging technique. Based on the anatomical information provided by H-1-images, SLOOP (Spatial Localization with Optimal Pointspread Function) allows to obtain spectra from defined compartments. With SLOOP a free voxel shape with adaption to anatomic structures, e.g. the myocardium, is possible. Absolute values for phosphocreatine (PCr) and adenosine triphosphate (ATP) were determined using an external standard. Results: P-31-spectra showed only minimal contamination by surrounding tissue. The standard deviation for the determined values of healthy volunteers was low. Compared to healthy volunteers, reduced PCr and ATP concentrations were seen for dilative cardiomyopathies and coronary artery disease and unchanged concentrations were observed for hypertensive heart disease. Conclusion: P-31-MR-spectroscopy with SLOOP allows a non-invasive, quantitative analysis of cardiac energy metabolism.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 12 条
  • [1] BEER M, 1998, FORTSCHR RONTGENS S1, V168, P75
  • [2] PHOSPHATE METABOLITE IMAGING AND CONCENTRATION MEASUREMENTS IN HUMAN HEART BY NUCLEAR-MAGNETIC-RESONANCE
    BOTTOMLEY, PA
    HARDY, CJ
    ROEMER, PB
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (03) : 425 - 434
  • [3] Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy
    Bottomley, PA
    Atalar, E
    Weiss, RG
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1996, 35 (05) : 664 - 670
  • [4] OPTIMUM FLIP-ANGLES FOR EXCITING NMR WITH UNCERTAIN T-1 VALUES
    BOTTOMLEY, PA
    OUWERKERK, R
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (01) : 137 - 141
  • [5] CARDIAC P-31-MR-SPECTROSCOPY IN MYOCARDIAL INSUFFICIENCY
    KRAHE, T
    SCHINDLER, R
    NEUBAUER, S
    ERTL, G
    HORN, M
    LACKNER, K
    [J]. FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1993, 159 (01): : 64 - 70
  • [6] Localized spectroscopy from anatomically matched compartments:: Improved sensitivity and localization for cardiac 31P MRS in humans
    Löffler, R
    Sauter, R
    Kolem, H
    Haase, A
    von Kienlin, M
    [J]. JOURNAL OF MAGNETIC RESONANCE, 1998, 134 (02) : 287 - 299
  • [7] Meininger M, 1999, MAGNET RESON MED, V41, P657, DOI 10.1002/(SICI)1522-2594(199904)41:4<657::AID-MRM3>3.0.CO
  • [8] 2-I
  • [9] P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN DILATED CARDIOMYOPATHY AND CORONARY-ARTERY DISEASE - ALTERED CARDIAC HIGH-ENERGY PHOSPHATE-METABOLISM IN HEART-FAILURE
    NEUBAUER, S
    KRAHE, T
    SCHINDLER, R
    HORN, M
    HILLENBRAND, H
    ENTZEROTH, C
    MADER, H
    KROMER, EP
    RIEGGER, GAJ
    LACKNER, K
    ERTL, G
    [J]. CIRCULATION, 1992, 86 (06) : 1810 - 1818
  • [10] Improved method for accurate and efficient quantification of MRS data with use of prior knowledge
    Vanhamme, L
    van den Boogaart, A
    Van Huffel, S
    [J]. JOURNAL OF MAGNETIC RESONANCE, 1997, 129 (01) : 35 - 43